Pharmacy Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacy, including details on drug stores, prescriptions, health care.

Volume 3 (2007), Issue 10 (October)

1. Distributive syringe sharing among young adult injection drug users in five U.S. cities.
   Drug Alcohol Depend, 91: S30-8. [Abstract] [Full-text]
2. Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability.
   Int J Pharm, 344(1): 150-3. [Abstract] [Full-text]
3. 'Uppers' keep going up.
   Br J Psychiatry, 191: 279-81. [Abstract] [Full-text]
4. A review of recorded information given to patients starting to take clozapine and the development of guidelines on disclosure, a key component of informed consent.
   J Med Ethics, 33(10): 564-7. [Abstract] [Full-text]
5. The Journey to the DNP Program and Beyond: What Can We Learn From Pharmacy?
   J Prof Nurs, 23(5): 316-21. [Abstract] [Full-text]
6. Patterns and predictors of statin use after coronary artery bypass graft surgery.
   J Thorac Cardiovasc Surg, 134(4): 932-8. [Abstract] [Full-text]
7. Medicare part D data: major changes on the horizon.
   Med Care, 45(10): S9-12. [Abstract] [Full-text]
8. Out-of-pocket pharmacy expenditures for veterans under medicare part D.
   Med Care, 45(10): S77-80. [Abstract] [Full-text]
9. Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans.
   Med Care, 45(10): S29-37. [Abstract] [Full-text]
10. A cluster randomized trial protocol to evaluate electronic prescribing in an ambulatory care setting.
    Trials, 8(1): 28. [Abstract] [Full-text]
11. Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disorders.
    Psychiatr Serv, 58(10): 1285-91. [Abstract] [Full-text]
12. Monitoring quality standards in the provision of non-prescription medicines from Australian Community Pharmacies: results of a national programme.
    Qual Saf Health Care, 16(5): 354-8. [Abstract] [Full-text]
13. Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers.
    Clin Gastroenterol Hepatol, 5(10): 1154-1159.e3. [Abstract] [Full-text]
14. Preventing adverse drug events in hospital practice: an overview.
    Pharmacoepidemiol Drug Saf, 16(10): 1129-35. [Abstract] [Full-text]
15. Pricing behaviour of pharmacies after market deregulation for OTC drugs: the case of Germany.
    Health Policy, 84(1): 30-8. [Abstract] [Full-text]
16. Toxic metals and organochlorine pesticides residue in single herbal drugs used in important ayurvedic formulation - 'Dashmoola'
    Environ Monit Assess. [Abstract] [Full-text]
17. Benzocaine-induced methemoglobinemia based on the Mayo Clinic experience from 28 478 transesophageal echocardiograms: incidence, outcomes, and predisposing factors.
    Arch Intern Med, 167(18): 1977-82. [Abstract] [Full-text]
18. Access to Multilingual Medication Instructions at New York City Pharmacies.
    J Urban Health. [Abstract] [Full-text]
19. Flavonoids in horse chestnut (Aesculus hippocastanum) seeds and powdered waste water byproducts.
    J Agric Food Chem, 55(21): 8485-90. [Abstract] [Full-text]
20. Look-alike medications: a formula for possible morbidity and mortality in the long-term care facility.
    J Am Med Dir Assoc, 8(8): 541-2. [Abstract] [Full-text]
21. Drug costs and use in VHA nursing homes: a national overview of long-stay residents.
    J Am Med Dir Assoc, 8(8): 515-8. [Abstract] [Full-text]
22. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.
    Neuroepidemiology, 28(4): 193-6. [Abstract] [Full-text]
23. Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution.
    Br J Clin Pharmacol, 64(5): 680-5. [Abstract] [Full-text]
24. Step by step development of clinical care pathways for older cancer patients: Necessary or desirable?
    Eur J Cancer, 43(15): 2170-8. [Abstract] [Full-text]
25. Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995-2005.
    Addiction, 102(11): 1824-30. [Abstract] [Full-text]
26. Patterns of adherence to oral methadone: Implications for prescribers.
    J Subst Abuse Treat. [Abstract] [Full-text]
27. Injury Among Stimulant-Treated Youth With ADHD.
    J Atten Disord. [Abstract] [Full-text]
28. Does hospitalisation affect hypnotic and anxiolytic drug prescribing?
    Pharm World Sci, 29(6): 611-8. [Abstract] [Full-text]
29. Utilization of antimicrobial agents with and without prescription by out-patients in selected pharmacies in South-eastern Nigeria.
    Pharm World Sci, 29(6): 655-60. [Abstract] [Full-text]
30. Information provided by generic and brand-name pharmaceutical manufacturers in response to a request.
    Pharm World Sci, 29(6): 683-7. [Abstract] [Full-text]
31. Quantity and quality of potential drug interactions with coumarin anticoagulants in the Netherlands.
    Pharm World Sci, 29(6): 671-5. [Abstract] [Full-text]
32. Differences in the association between structural factors and diabetes self-monitoring support.
    Pharm World Sci, 29(6): 676-82. [Abstract] [Full-text]
33. Implementation of a pharmaceutical care service: prescriptionists', pharmacists' and doctors' views.
    Pharm World Sci, 29(6): 593-602. [Abstract] [Full-text]
34. Survey of drug-related problems identified by community pharmacies.
    Ann Pharmacother, 41(11): 1825-32. [Abstract] [Full-text]
35. Factors related to adherence to statin therapy.
    Ann Pharmacother, 41(11): 1805-11. [Abstract] [Full-text]
36. Healthcare without conscience--unconscionable!
    Ann Pharmacother, 41(11): 1903-5. [Abstract] [Full-text]
37. Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management.
    Ann Pharmacother, 41(11): 1770-81. [Abstract] [Full-text]
38. Consequences of poor compliance with bisphosphonates.
    Bone, 41(5): 882-7. [Abstract] [Full-text]
39. Antiarrhythmic effect of newly synthesized compound 44Bu on model of aconitine-induced arrhythmia -- compared to lidocaine.
    Eur J Pharmacol, 575(1): 127-33. [Abstract] [Full-text]
40. The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls.
    J Adolesc Health, 41(5): 455-63. [Abstract] [Full-text]
41. Gender and use of care: planning for tomorrow's Veterans Health Administration.
    J Womens Health (Larchmt), 16(8): 1188-99. [Abstract] [Full-text]
42. Pharmacy discounts on generic medicines in France: is there room for further efficiency savings?
    Curr Med Res Opin, 23(10): 2467-76. [Abstract] [Full-text]
43. Instruction on compounded sterile preparations at U.S. schools of pharmacy.
    Am J Health Syst Pharm, 64(21): 2267-74. [Abstract] [Full-text]
44. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS).
    Invest Ophthalmol Vis Sci, 48(11): 5052-7. [Abstract] [Full-text]
45. Are patients reliable when self-reporting medication use? Validation of structured drug interviews and home visits by drug analysis and prescription data in acutely hospitalized patients.
    J Clin Pharmacol, 47(11): 1440-9. [Abstract] [Full-text]
46. Impact of prescription size on statin adherence and cholesterol levels.
    BMC Health Serv Res, 7(1): 175. [Abstract] [Full-text]
47. Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome.
    Am Heart J, 154(5): 846-51. [Abstract] [Full-text]
48. Access to Affordable Medications: The Department of Veterans Affairs Pharmacy Plan as a National Model.
    Am J Public Health. [Abstract] [Full-text]

© 2005-2008 Pharmacy Research Today. All Rights Reserved.